Drug Approval

FDA FDA Approval FDA Regulations Regulatory Affairs FDA Approvals Semaglutide Anvisa NHS Treatments NHS Innovations EMA

FDA Approves Lipfendra, First Oral PCSK9 Pill for High LDL

Merck priced the once-daily 20 mg tablet below injectable alternatives to expand access while a large cardiovascular outcomes trial runs through 2029.

6 ARTICLES

last mo.

Autism Leucovorin Prescriptions Jump 2,000% After Media and White House Promotion

4 ARTICLES

3mo ago

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma

9 ARTICLES

3mo ago

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

3 ARTICLES

3mo ago

FDA Approves Bizengri for NRG1 Fusion Cholangiocarcinoma Under Accelerated Pathway

5 ARTICLES

3mo ago

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

5 ARTICLES

3mo ago

Anvisa Approves Mounjaro for Type 2 Diabetes in Children Ages 10–17

4 ARTICLES

3mo ago

NICE Recommends Zanidatamab for NHS Use in HER2-Positive Biliary Tract Cancer

4 ARTICLES

4mo ago

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

7 ARTICLES

4mo ago

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

9 ARTICLES

4mo ago

FDA Approves First Glucocorticoid Receptor Blocker for Platinum-Resistant Ovarian Cancer

3 ARTICLES

4mo ago

FDA Approves Nivolumab Plus AVD as First-Line Therapy for Advanced Hodgkin Lymphoma

3 ARTICLES

8mo ago

FDA Approves Breyanzi for Marginal Zone Lymphoma After Two or More Therapies

7 ARTICLES

9mo ago

FDA Approves Komzifti, First Menin Inhibitor for Relapsed NPM1‑Mutant AML

8 ARTICLES

9mo ago

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

8 ARTICLES

10mo ago

Datroway Extends Survival Over Chemotherapy in First-Line TNBC Ineligible for Immunotherapy

3 ARTICLES

10mo ago

FDA Approves Zoryve 0.05% Cream for Children Ages 2–5 With Mild to Moderate Atopic Dermatitis

Drug Approval

FDA Approves Lipfendra, First Oral PCSK9 Pill for High LDL

FDA Approves Utebzi as First Oral Carbapenem for Complicated UTIs

NHS Approves First New Ovarian Cancer Drug in 20 Years

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

Autism Leucovorin Prescriptions Jump 2,000% After Media and White House Promotion

FDA Grants Accelerated Approval to First BCL2 Drug for Relapsed Mantle Cell Lymphoma

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

FDA Approves Bizengri for NRG1 Fusion Cholangiocarcinoma Under Accelerated Pathway

FDA Expands Tzield Use to Delay Type 1 Diabetes in Children Ages 1 to 7

Anvisa Approves Mounjaro for Type 2 Diabetes in Children Ages 10–17

Never miss stories about

Drug Approval

NICE Recommends Zanidatamab for NHS Use in HER2-Positive Biliary Tract Cancer

FDA Grants Accelerated Approval to Lilly’s Oral Weight-Loss Pill Foundayo

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

FDA Approves First Glucocorticoid Receptor Blocker for Platinum-Resistant Ovarian Cancer

FDA Approves Nivolumab Plus AVD as First-Line Therapy for Advanced Hodgkin Lymphoma

FDA Approves Breyanzi for Marginal Zone Lymphoma After Two or More Therapies

FDA Approves Komzifti, First Menin Inhibitor for Relapsed NPM1‑Mutant AML

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

Datroway Extends Survival Over Chemotherapy in First-Line TNBC Ineligible for Immunotherapy

FDA Approves Zoryve 0.05% Cream for Children Ages 2–5 With Mild to Moderate Atopic Dermatitis

Never miss stories about

Drug Approval